000504 Landfar Bio-medicine
- 6.95
- +0.01+0.14%
Landfar Bio-medicine News
Nanhua Biotech: Semi-annual summary of non-operating capital consumption and other related capital transactions
Nanhua Biotech: Nanhua Biotech\'s announcement on anticipated related transactions
Nanhua Biotech: 2024 Semi-Annual Report Summary
Nanhua Biotech: Nanhua Biotech\'s Special Report on the Storage and Use of Raised Funds for the 2024 Semi-Annual Period
Nanhua Biotech: 2024 Semi-Annual Financial Report
Nanhua Biotech: Semi-Annual Report Board Resolution Announcement
Nanhua Biotech: Western Securities\'s Verification Opinions on Anticipated Transactions Related to Nanhua Biopharmaceutical Co., Ltd.
Nanhua Biotech: Semi-Annual Report Supervisory Board Resolutions Announcement
Nanhua Biotech: 2024 Semi-Annual Report
Landfar Bio-medicine: Announcement on the Progress of Litigation Matters of Subsidiary Controlled by Landfar Bio-Medicine
Landfar Bio-medicine: Announcement about the Resignation of Independent Director of Landfar Bio-Medicine.
Landfar Bio-medicine: Announcement on Landfar Bio-Medicine's Lawsuit Against its Holding Subsidiary
Landfar Bio-medicine: Announcement of the Progress of Legal Proceedings Regarding the Controlling Subsidiary of Landfar Bio-Medicine
Landfar Bio-medicine: Announcement of Landfar Bio-Medicine on Filing a Lawsuit against Its Subsidiary
Landfar Bio-medicine: 2024 Interim Performance Forecast
Landfar Bio-medicine: Announcement on the Progress of Litigation Matters of Subsidiary Controlled by Landfar Bio-Medicine
Landfar Bio-medicine: Announcement of abnormal fluctuations in the trading of Landfar Bio-Medicine stocks.
Landfar Bio-medicine: Legal Opinion on Nanhua Biotech's 2023 Annual General Meeting of Shareholders
Landfar Bio-medicine: Announcement of Resolutions of Nanhua Biotech's 2023 Annual General Meeting of Shareholders
Landfar Bio-medicine: Nanhua Biotech Stock Trading Abnormal Fluctuation Notice
Analysis
Price Target
No Data
